A Structure-Guided Approach to an Orthogonal Estrogen-Receptor-Based Gene Switch Activated by Ligands Suitable for in Vivo Studies
Journal of Medicinal Chemistry2006Vol. 49(18), pp. 5404–5407
Citations Over Time
Olaf Kinzel, Daniela Fattori, Ester Muraglia, Paola Gallinari, Maria Chiara Nardi, Chantal Paolini, Giuseppe Roscilli, Carlo Toniatti, Odalys Gonzalez Paz, Ralph Laufer, Armin Lahm, Anna Tramontano, Riccardo Cortese, Raffaele De Francesco, Gennaro Ciliberto, Uwe Koch
Abstract
A strategy to obtain a fully orthogonal estrogen-receptor-based gene switch responsive to molecules with acceptable pharmacological properties is presented. From a series of tetrahydrofluorenones active on the wild-type estrogen receptor (ER) an inactive analogue is chosen as a new lead compound. Coevolution of receptor mutants and ligands leads to an ER-based gene switch suitable for studies in animal models.
Related Papers
- → Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice(2003)470 cited
- → Estrogen Receptor-Related Receptor α: A Mediator of Estrogen Response in Bone(2005)75 cited
- → Estrogen-induced downregulation of TASK-1 expression through estrogen receptor β in N2A cells(2021)1 cited
- → Estrogen and estrogen receptors of breast cancer(1975)3 cited
- [Expression of human estrogen receptor alpha and beta in Escherichia coli].(2012)